Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
Por:
Vivas, D, Roldan, V, Esteve-Pastor, M, Roldan, I, Tello-Montoliu, A, Ruiz-Nodar, J, Cosin-Sales, J, Gamez, J, Consuegra, L, Ferreiro, J, Marin, F, Arrarte, V, Anguita, M, Cequier, A and Perez-Villacastin, J
Publicada:
1 sep 2020
Categoría:
Cardiology and cardiovascular medicine
Resumen:
The new coronavirus SARS-CoV-2, which gives rise to the highly contagious COVID-19 disease, has caused a pandemic that is overwhelming health care systems worldwide. Affected patients have been reported to have a heightened inflammatory state that increases their thrombotic risk. However, there is very scarce information on the management of thrombotic risk, coagulation disorders, and anticoagulant therapy. In addition, the situation has also greatly influenced usual care in patients not infected with COVID-19. This article by the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology aims to summarize the available information and to provide a practical approach to the management of antithrombotic therapy. (C) 2020 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
Filiaciones:
Vivas, D:
Hosp Clin San Carlos, Inst Cardiovasc, Madrid, Spain
Roldan, V:
Univ Murcia, Hosp Univ Morales Meseguer, IMIB Arrixaca, CIBERCV,Serv Hematol, Murcia, Spain
Esteve-Pastor, M:
Univ Murcia, Hosp Clin Univ Virgen Arrixaca, IMIB Arrixaca, CIBERCV,Serv Cardiol, Murcia, Spain
Roldan, I:
Hosp Gen Univ La Paz, Serv Cardiol, CIBERCV, Madrid, Spain
Tello-Montoliu, A:
Univ Murcia, Hosp Clin Univ Virgen Arrixaca, IMIB Arrixaca, CIBERCV,Serv Cardiol, Murcia, Spain
Ruiz-Nodar, J:
Univ Miguel Hernandez, Hosp Gen Univ Alicante, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Serv Cardiol,CIBERCV, Alicante, Spain
:
Hosp Arnau Vilanova, Serv Cardiol, Valencia, Spain
Univ Cardenal Herrera CEU, Fac Ciencias Salud, Dept Med, Valencia, Spain
Gamez, J:
Univ Islas Baleares, Hosp Univ Son Llatzer, Fac Med, Dept Med,Serv Cardiol, Palma De Mallorca, Spain
Consuegra, L:
Hosp Gen Univ Santa Lucia, Serv Cardiol, Murcia, Spain
Ferreiro, J:
Hosp Univ Bellvitge IDIBELL, CIBERCV, Serv Cardiol, Barcelona, Spain
Marin, F:
Univ Murcia, Hosp Clin Univ Virgen Arrixaca, IMIB Arrixaca, CIBERCV,Serv Cardiol, Murcia, Spain
Arrarte, V:
Univ Miguel Hernandez, Hosp Gen Univ Alicante, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Serv Cardiol,CIBERCV, Alicante, Spain
Anguita, M:
Hosp Univ Reina Sofia, Serv Cardiol, Cordoba, Spain
Cequier, A:
Hosp Univ Bellvitge IDIBELL, CIBERCV, Serv Cardiol, Barcelona, Spain
Perez-Villacastin, J:
Hosp Clin San Carlos, Inst Cardiovasc, Madrid, Spain
Green Published
FULL TEXT
 |
Published Version |
This policy does not allow for Open Access for this version |
| No Accesible |
|